Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,283 | 547 | 96.4% |
| Gift | $165.96 | 1 | 1.7% |
| Entertainment | $119.28 | 1 | 1.2% |
| Education | $62.99 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,607 | 185 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,224 | 67 | $0 (2024) |
| Celgene Corporation | $618.37 | 48 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $578.67 | 38 | $0 (2024) |
| Janssen Biotech, Inc. | $571.01 | 40 | $0 (2024) |
| Romark Laboratories, LC | $323.50 | 17 | $0 (2020) |
| Braintree Laboratories, Inc. | $312.49 | 11 | $0 (2024) |
| Gilead Sciences, Inc. | $297.93 | 18 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $283.63 | 18 | $0 (2023) |
| Allergan Inc. | $176.25 | 14 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,553 | 73 | ABBVIE INC. ($675.31) |
| 2023 | $1,481 | 87 | AbbVie Inc. ($465.12) |
| 2022 | $1,867 | 105 | ABBVIE INC. ($600.32) |
| 2021 | $1,139 | 66 | AbbVie Inc. ($530.39) |
| 2020 | $538.41 | 31 | AbbVie Inc. ($260.13) |
| 2019 | $1,066 | 68 | Braintree Laboratories, Inc. ($179.73) |
| 2018 | $1,051 | 61 | AbbVie, Inc. ($409.76) |
| 2017 | $936.24 | 60 | AbbVie, Inc. ($498.82) |
All Payment Transactions
551 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Immunology | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $13.84 | General |
| Category: GI | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: LIVER DISEASE | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/22/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Rare Disease | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $34.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Gastroenterology | ||||||
| 10/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/27/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Immunology | ||||||
| 09/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.93 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 608 | 625 | $794,033 | $71,728 |
| 2022 | 13 | 631 | 666 | $791,579 | $74,743 |
| 2021 | 13 | 651 | 686 | $844,921 | $81,010 |
| 2020 | 9 | 494 | 515 | $639,817 | $57,876 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 141 | 142 | $276,900 | $27,607 | 10.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 149 | 149 | $238,200 | $14,136 | 5.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 98 | 99 | $125,037 | $8,556 | 6.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 57 | $14,136 | $5,029 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 60 | $9,720 | $3,662 | 37.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 18 | 18 | $27,000 | $3,023 | 11.2% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 13 | 14 | $36,904 | $2,295 | 6.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $25,500 | $2,150 | 8.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $7,809 | $2,100 | 26.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $20,425 | $1,655 | 8.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,402 | $991.44 | 29.1% |
| 43450 | Dilation of esophagus | Facility | 2023 | 18 | 18 | $9,000 | $524.70 | 5.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 149 | 149 | $290,550 | $28,292 | 9.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 112 | 113 | $180,800 | $10,419 | 5.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 104 | 108 | $136,404 | $9,358 | 6.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 33 | 33 | $49,500 | $5,662 | 11.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 62 | $15,376 | $5,344 | 34.8% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 12 | 15 | $42,000 | $4,520 | 10.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 78 | $12,636 | $4,382 | 34.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 15 | 16 | $24,000 | $2,044 | 8.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $7,398 | $1,925 | 26.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $13,975 | $1,050 | 7.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $3,240 | $920.17 | 28.4% |
| 43450 | Dilation of esophagus | Facility | 2022 | 27 | 27 | $13,500 | $744.19 | 5.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 22 | 22 | $2,200 | $83.16 | 3.8% |
About Arthur Baluyut, MD PHD
Arthur Baluyut, MD PHD is a Gastroenterology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1669474292.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Arthur Baluyut, MD PHD has received a total of $9,631 in payments from pharmaceutical and medical device companies, with $1,553 received in 2024. These payments were reported across 551 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($9,283).
As a Medicare-enrolled provider, Baluyut has provided services to 2,384 Medicare beneficiaries, totaling 2,492 services with total Medicare billing of $285,358. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Indianapolis, IN
- Active Since 08/12/2005
- Last Updated 10/23/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1669474292
Products in Payments
- XIFAXAN (Drug) $1,037
- RINVOQ (Biological) $764.86
- HUMIRA (Biological) $714.50
- Humira (Biological) $661.93
- ZEPOSIA (Drug) $606.16
- SKYRIZI (Biological) $543.53
- STELARA (Biological) $394.34
- ZENPEP (Drug) $371.35
- LINZESS (Drug) $341.85
- ENTYVIO (Biological) $325.37
- DUPIXENT (Biological) $263.51
- Alinia Tablets 500mg 30 count bottle (Drug) $220.86
- Mavyret (Drug) $215.23
- TRULANCE (Drug) $212.96
- SUPREP BOWEL PREP (Drug) $165.96
- XELJANZ (Drug) $159.77
- Creon (Drug) $147.83
- Entyvio (Biological) $133.83
- Cimzia (Drug) $128.65
- CREON (Drug) $121.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Indianapolis
Douglas Rex, M.d, M.D
Gastroenterology — Payments: $785,487
Ajay Jain, Md, MD
Gastroenterology — Payments: $435,795
Dr. David Pound, M.d, M.D
Gastroenterology — Payments: $207,527
Raj Vuppalanchi, M.d, M.D
Gastroenterology — Payments: $183,853
Thomas Imperiale, M.d, M.D
Gastroenterology — Payments: $154,570
Glen Lehman, M.d, M.D
Gastroenterology — Payments: $98,291